4.4 Article

The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic

期刊

NEUROGASTROENTEROLOGY AND MOTILITY
卷 34, 期 9, 页码 -

出版社

WILEY
DOI: 10.1111/nmo.14347

关键词

COVID-19 pandemic; disorders of gut-brain interaction; Irritable Bowel Syndrome

向作者/读者索取更多资源

This study demonstrates that patients with refractory IBS seen in tertiary care during the COVID-19 pandemic experienced significantly higher symptom burden, highlighting the importance of the gut-brain axis in IBS. Lack of support and perceived loss of control appear to be contributing factors.
Background The COVID-19 pandemic caused unprecedented disruption to healthcare services worldwide with well-documented detrimental effects on mental health. Patients with refractory disorders of gut-brain interaction such as Irritable Bowel Syndrome (IBS) seen in tertiary care tend to exhibit higher levels of psychological comorbidity, but the impact of the pandemic on IBS symptom severity in tertiary care is unknown. Methods As part of routine clinical care, consecutive tertiary referrals with refractory IBS patients prospectively completed a series of baseline questionnaires including IBS symptom severity score (IBS-SSS), non-colonic symptom score, Hospital Anxiety and Depression (HAD), and Illness impact scores. The symptom severity questionnaire data were compared for consecutive patients seen in tertiary care 12 months before and after the onset of COVID-19 pandemic restrictions. Key Results Of 190 consecutive tertiary referrals with IBS, those seen during the pandemic had greater IBS severity (IBS-SSS: 352 vs. 318, p = 0.03), more severe extra-intestinal symptoms (non-colonic score: 269 vs. 225, p = 0.03), sleep difficulties (p = 0.03), helplessness and loss of control (p = 0.02), but similar HAD-Anxiety (p = 0.96) and HAD-Depression (p = 0.84) scores. During the pandemic, unmarried patients (p = 0.03), and keyworkers (p = 0.0038) had greater IBS severity. Conclusions and Inferences This study has shown for the first time that patients seen in tertiary care with refractory IBS during the COVID-19 pandemic had a significantly higher symptom burden emphasizing the importance of gut-brain axis in IBS. Furthermore, lack of support and perceived loss of control appear to be contributory factors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Gastroenterology & Hepatology

Twitter debate: controversies in dysphagia

Aditi Kumar, Gaurav B. Nigam, Dipesh Harshvadan Vasant, Anjan Dhar

FRONTLINE GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

British Society of Gastroenterology guidelines on the management of functional dyspepsia

Christopher J. Black, Peter A. Paine, Anurag Agrawal, Imran Aziz, Maria P. Eugenicos, Lesley A. Houghton, Pali Hungin, Ross Overshott, Dipesh H. Vasant, Sheryl Rudd, Richard C. Winning, Maura Corsetti, Alexander C. Ford

Summary: This research aims to review and summarize the current evidence on functional dyspepsia, provide a practical framework for evidence-based diagnosis and treatment of patients, and provide specific recommendations based on the GRADE system. The study also considers the development of novel treatment methods and highlights areas of unmet need and priorities for future research.
Article Gastroenterology & Hepatology

Regional survey of foundation trainee doctors' views on a career in gastroenterology: implications for diversity and inclusion

Umair Akbani, Dipesh Harshvadan Vasant

Summary: This study investigated the perceptions of foundation doctors towards gastroenterology and identified gender differences in specialty selection factors. The results showed that female doctors value patient-centred care and good mentorship, while male doctors prioritize income and length of training. Female doctors had negative perceptions of the male dominant existing workforce and the requirement to be a medical registrar in gastroenterology. Increasing flexibility in training and providing more exposure and mentorship during the foundation years may improve diversity in the specialty.

FRONTLINE GASTROENTEROLOGY (2023)

Review Gastroenterology & Hepatology

Current and future perspectives on the utility of provocative tests of anal sphincter function: A state-of-the-art summary

Alexander O'Connor, Caroline M. Byrne, Dipesh H. Vasant, Abhiram Sharma, Donghua Liao, Niels Klarskov, Edward S. Kiff, Karen Telford

Summary: This review presents the current and potential future applications of AAR and FLIP techniques, highlighting the unanswered questions associated with these novel technologies.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

The prevalence and burden of Rome IV faecal incontinence in ulcerative colitis: A cross-sectional study

Dipesh H. Vasant, Gaurav B. Nigam, Sebastian Bate, Shaheen Hamdy, Jimmy K. Limdi

Summary: Despite advances in UC therapies, a proportion of patients experience fecal incontinence (FI) in the absence of active inflammation. In a prospective study, the prevalence and impact of FI in UC were estimated.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study

Hussain Jaafari, Lesley A. Houghton, Robert M. West, Anurag Agrawal, Imran Aziz, Christopher J. Black, Maura Corsetti, Farag Shuweihdi, Maria Eugenicos, Peter A. Paine, Alexander C. Ford, Peter J. Whorwell, Shrikant I. Bangdiwala, Olafur S. Palsson, Ami D. Sperber, Dipesh H. Vasant

Summary: This study compared the prevalence of disorders of gut brain interaction (DGBI) in the UK with other countries and found that the proportion of DGBI participants was lower in the UK. The prevalence of 14 out of 22 Rome IV DGBI was similar between the UK and other countries, while some specific DGBI were more prevalent in the UK. Differences in opioid prescribing, cultural, dietary, and lifestyle factors may contribute to variations in the prevalence of DGBI between the UK and other countries.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

A comparative study of disorders of gut-brain interaction in Western Europe and Asia based on the Rome foundation global epidemiology study

Johann P. Hreinsson, Reuben K. M. Wong, Jan Tack, Peter Whorwell, Marc A. Benninga, Viola Andresen, Bruno Bonaz, Suck Chei Choi, Enrico S. Corazziari, Javier Santos, Shin Fukudo, Motoyori Kanazawa, Xuicai Fang, Shrikant I. Bangdiwala, Ami D. Sperber, Olafur S. Palsson, Magnus Simren

Summary: This study compared the prevalence of gut-brain interaction disorders (DGBI) between Asia and Western Europe, and found that DGBI is generally more prevalent in Western Europe, which is associated with severe psychological and non-GI somatic symptoms.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Review Gastroenterology & Hepatology

Improving access to gut-directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a smart solution?

Syed S. Hasan, Sarah Ballou, Laurie Keefer, Dipesh H. Vasant

Summary: Gut-directed hypnotherapy (GDH) is a highly effective behavioral therapy recommended for the treatment of irritable bowel syndrome (IBS). GDH has been recognized as a valuable addition to integrated care alongside medical and dietary approaches. Recent innovations, such as smartphone app-delivered GDH, have improved access to this therapy despite low adherence rates.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Multidisciplinary Sciences

The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study

Huw Purssell, Lucy Bennett, Oliver Street, Karen Piper Hanley, Neil Hanley, Dipesh H. Vasant, Varinder S. Athwal

Summary: The study evaluated the prevalence and burden of Rome IV irritable bowel syndrome (IBS) in patients with non-alcoholic fatty liver disease (NAFLD). It found that 55.6% of NAFLD patients had Rome IV bowel disorders of gut brain interaction (DGBI), with 35.2% meeting the criteria for IBS. Rome IV bowel DGBI, such as IBS, are associated with impaired quality-of-life (QoL) and psychosocial distress.

SCIENTIFIC REPORTS (2023)

Article Psychology, Clinical

The Emerging New Reality of Hypnosis Teletherapy: A Major New Mode of Delivery of Hypnotherapy and Clinical Hypnosis Training

Syed Shariq Hasan, Dipesh Vasant

Summary: Remote hypnotherapy is increasingly used internationally, especially after the COVID-19 pandemic. Video-based remote hypnotherapy is more popular and effective compared to telephone therapy, improving access to treatment. Patient satisfaction and practical considerations should be taken into account when deciding on the mode of delivery.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL HYPNOSIS (2023)

Article Gastroenterology & Hepatology

Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis

Jade Devenney, Syed S. Hasan, Julie Morris, Peter J. Whorwell, Dipesh H. Vasant

Summary: This study conducted a secondary analysis of gut-directed hypnotherapy outcomes in patients with refractory IBS and found that patients with a higher burden of gastrointestinal and extraintestinal symptoms are most likely to benefit from this treatment. Clinical assessment of gastrointestinal, somatic, and psychological symptom profiles may play a role in selecting patients for gut-directed hypnotherapy.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

The consequences of limited training in disorders of gut-brain interaction: Results from a national survey of gastroenterology trainees in the United Kingdom

Ayodele Sasegbon, Yuying Luo, Laurie A. Keefer, Dipesh H. Vasant

Summary: Despite the high prevalence and burden of disorders of gut-brain interaction (DGBI), there is limited teaching on this topic in medical curricula. This study evaluated the exposure and comfort levels of UK gastroenterology trainees in diagnosing and managing DGBI. Findings suggest that most trainees lack confidence in dealing with DGBI.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Review Gastroenterology & Hepatology

Identifying the need for a UK colorectal cancer screening programme for patients with cystic fibrosis (CF): 10-year retrospective review of colonoscopy and colorectal cancer outcomes at a single CF centre

Karuna Sapru, Peter Barry, Andrew Jones, John Walmsley, Javaid Iqbal, Dipesh H. Vasant

Summary: Patients with cystic fibrosis (pwCF) have a high incidence of early colorectal cancer (CRC). This study evaluated the utility and outcomes of colonoscopy and CRC at a large UK CF centre. The results showed that the uptake of colonoscopy among pwCF was low, but it was highly effective for detecting premalignant lesions in patients over 40 years old.

BMJ OPEN GASTROENTEROLOGY (2023)

暂无数据